Loading...

Johnson & Johnson

JNJNYSE
Healthcare
Drug Manufacturers - General
$168.30
$-1.26(-0.74%)

Johnson & Johnson (JNJ) Financial Performance & Income Statement Overview

Review Johnson & Johnson’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
4.30%
4.30%
Operating Income Growth
-5.38%
5.38%
Net Income Growth
-59.99%
59.99%
Operating Cash Flow Growth
6.47%
6.47%
Operating Margin
24.42%
24.42%
Gross Margin
67.92%
67.92%
Net Profit Margin
25.005%
25.005%
ROE
30.39%
30.39%
ROIC
15.90%
15.90%

Johnson & Johnson (JNJ) Income Statement & Financial Overview

Review Johnson & Johnson's (JNJ) income statement with detailed quarterly and annual figures.

MetricQ2 2025Q1 2025Q4 2024Q3 2024
Revenue$0.00$21.89B$22.52B$22.47B
Cost of Revenue$0.00$7.36B$7.13B$6.96B
Gross Profit$16.11B$14.54B$15.39B$15.51B
Gross Profit Ratio$0.00$0.66$0.68$0.69
R&D Expenses$3.52B$3.23B$5.30B$4.95B
SG&A Expenses$5.89B$5.01B$6.25B$5.28B
Operating Expenses$9.40B$8.24B$11.55B$10.23B
Total Costs & Expenses$0.00$15.59B$18.68B$17.19B
Interest Income$0.00$332.00M$281.00M$292.00M
Interest Expense$48.00M$204.00M$137.00M$193.00M
Depreciation & Amortization$0.00$1.77B$1.90B$1.85B
EBITDA$6.71B$15.61B$5.92B$5.38B
EBITDA Ratio$0.00$0.71$0.26$0.24
Operating Income$6.71B$6.30B$3.84B$5.28B
Operating Income Ratio$0.00$0.29$0.17$0.23
Other Income/Expenses (Net)-$219.00M$7.33B$46.00M-$1.94B
Income Before Tax$6.49B$13.63B$3.89B$3.34B
Income Before Tax Ratio$0.00$0.62$0.17$0.15
Income Tax Expense$954.00M$2.63B$456.00M$644.00M
Net Income$5.54B$11.00B$3.43B$2.69B
Net Income Ratio$0.00$0.50$0.15$0.12
EPS$2.77$4.57$1.43$1.12
Diluted EPS$2.77$4.54$1.41$1.11
Weighted Avg Shares Outstanding$2.42B$2.41B$2.41B$2.41B
Weighted Avg Shares Outstanding (Diluted)$2.42B$2.42B$2.43B$2.43B

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;